U.S. Pharma Stock News

In early March 2026, Alto Ingredients reported fourth-quarter 2025 sales of US$231.97 million and net income of US$21.81 million, marking a shift from a loss a year earlier and delivering positive earnings per share for both the quarter and full year. This earnings release highlighted how portfolio realignment, improved crush margins, higher-value renewable fuel exports, and benefits from the 45Z clean fuel production credit collectively turned prior losses into profit across Alto’s...

United States Lime & Minerals (USLM) jumped 9.9% after the February ISM Manufacturing report highlighted rising input prices, which investors interpreted as potential pricing power and margin support for industrial suppliers. See our latest analysis for United States Lime & Minerals. That ISM driven jump comes on top of a 1 year total shareholder return of 30.39% and a very large 3 year total shareholder return of 294.55%, even though the year to date share price return is slightly negative...

S&P Global Ratings recently confirmed Freedom Holding Corp.’s long-term issuer credit rating at “B-” with a Stable outlook, while assigning Positive outlooks to key operating subsidiaries as the group expands its brokerage, banking, and broader financial ecosystem. The inclusion of newer areas such as telecommunications and artificial intelligence within Freedom Holding’s growing ecosystem highlights how the group is broadening its business mix beyond traditional financial services. We’ll...

Douglas Dynamics, Inc. has already reported fourth-quarter 2025 results, with sales rising to US$184.54 million and net income reaching US$12.84 million, alongside full-year 2025 sales of US$656.05 million and a quarterly dividend of US$0.295 per share declared for payment on March 31, 2026. Management’s 2026 net sales outlook of US$710 million to US$760 million, combined with higher quarterly earnings versus the prior year, has prompted analysts to reassess how earnings quality, demand...

Why Stepan’s latest earnings matter for shareholders Stepan (SCL) just released fourth quarter and full year 2025 results, pairing higher quarterly sales and net income with a goodwill impairment charge and a reaffirmed quarterly cash dividend of $0.395 per share. This mix of earnings, impairment and dividend news gives you a fresh look at how the chemical producer is balancing reported profitability, balance sheet adjustments and ongoing cash returns to shareholders. See our latest analysis...

In late February and early March 2026, analysts including Citi, Raymond James, and Barclays turned more cautious on American Homes 4 Rent, citing softer rental demand, elevated new supply, and rising concessions across single-family and multifamily markets. At Citi’s Miami Global Property CEO Conference 2026, American Homes 4 Rent outlined its response with a new US$500 million share repurchase authorization and plans to develop about 1,900 homes in 2026 while closely tracking legislative...

Quarterly earnings and dividend catch investors’ attention Smith & Wesson Brands (SWBI) recently reported third quarter results alongside a fresh dividend announcement. This gives investors new data on both operating performance and direct cash returns. For the quarter ended January 31, 2026, sales were US$135.71 million compared with US$115.89 million a year earlier, while net income was US$3.75 million versus US$2.10 million. See our latest analysis for Smith & Wesson Brands. The earnings...

Nurix Therapeutics recently amended its equity distribution agreement to allow sales of up to US$413.65 million of common stock through Piper Sandler under its existing shelf registration. This expanded at-the-market facility gives Nurix added funding flexibility, potentially affecting how investors assess its balance between capital needs and ownership dilution. We will now examine how this enlarged at-the-market capacity shapes Nurix’s investment narrative, particularly around funding...

In February 2026, Atlas Energy Solutions reported fourth-quarter 2025 revenue of US$249.43 million and a quarterly net loss of US$22.24 million, while full-year 2025 revenue rose to US$1.10 billion alongside a full-year net loss of US$50.30 million versus a profit the year before. Despite swinging to losses, Atlas highlighted record utilization of its Dune Express system and new initiatives in power generation aimed at broadening its revenue base beyond traditional sand and logistics. We’ll...

What triggered the latest move in Distribution Solutions Group? Distribution Solutions Group (DSGR) is back in focus after its fourth quarter and full year 2025 earnings missed analyst expectations on both revenue and earnings, pressuring margins and sparking legal scrutiny following a sharp share price reaction. See our latest analysis for Distribution Solutions Group. The sharp post earnings drop has fed into a wider reset in expectations, with a 7 day share price return of 26.12% and a...

Why Immunovant is back on investors’ radar Immunovant (IMVT) has drawn fresh attention after completing enrollment in a potentially registrational IMVT-1402 trial for difficult rheumatoid arthritis, alongside a roughly US$550 million capital raise from institutional investors. See our latest analysis for Immunovant. At a share price of US$26.66, Immunovant has recently seen a 15.06% 90 day share price return and a 33.17% 1 year total shareholder return. This suggests momentum has built over...

Pentair stock snapshot and recent performance Pentair (PNR) has been on many watchlists after a period of weaker share performance, with the stock showing negative returns over the past week, month, and past 3 months despite a positive 1 year total return. See our latest analysis for Pentair. At a share price of $92.17, Pentair’s recent 1 day, 7 day and 90 day share price returns have been negative, while its 1 year and 3 year total shareholder returns remain positive, suggesting shorter term...

In early March 2026, Mobix Labs, Inc. reported new production purchase orders for its high-reliability electromagnetic interference protection components used in Gulfstream business jets and the U.S. Navy’s Tomahawk cruise missile program, alongside a change to its bylaws reducing the shareholder meeting quorum requirement to one-third of voting power. The fresh aerospace and defense orders underline Mobix Labs’ role as an already-qualified supplier embedded in mission-critical platforms...

The weak February U.S. jobs report, which showed a loss of 92,000 jobs and unemployment at 4.4%, triggered a 3.6% drop in Enova International (ENVA), highlighting investor concern around credit conditions and demand. See our latest analysis for Enova International. That jobs-driven drop comes after a tougher few weeks for the share price, with a 30 day share price return of a 14.6% decline and a year to date share price return of a 15.05% decline, even though the 1 year total shareholder...

If you are wondering whether Casella Waste Systems at around US$94.03 is a fair deal or a stretch, you are not alone. This article focuses squarely on what the current price might imply about value. The stock has moved 0.9% over the past week, while showing a 10.1% decline over 30 days, a 4.7% decline year to date, a 16.4% decline over 1 year, but gains of 24.7% over 3 years and 45.3% over 5 years. Recent price moves sit against a backdrop where investors are watching the waste and recycling...

Federal Signal (NYSE:FSS) reported record quarterly and full year results, with net sales and adjusted EPS at the highest levels in the company’s history. The company announced a meaningful dividend increase alongside these results. Federal Signal also appointed two experienced executives to its board of directors. Federal Signal, listed on the NYSE under ticker FSS, focuses on safety and environmental solutions, including equipment and systems used by municipal, industrial, and commercial...

CorMedix Inc. has reported past fourth-quarter 2025 revenue of US$128.62 million and net income of US$14.02 million, capping a year in which full-year revenue reached US$311.71 million and net income swung to US$163.06 million from a prior loss. The company’s reiteration of 2026 net revenue guidance of US$300 million to US$320 million, alongside advancing late-stage trials for REZZAYO and other pipeline assets, highlights management’s focus on consolidating recent product gains while...

Dream Finders Homes (DFH) has drawn investor attention after recent trading left the stock at US$16.40, with declines over the past week, month, and past 3 months raising questions about what is priced in. See our latest analysis for Dream Finders Homes. At US$16.40, the recent 1 day, 7 day and 30 day share price returns of 4.93%, 9.24% and 16.20% respectively point to fading near term momentum. The 1 year total shareholder return of 35.36% contrasts with a 3 year total shareholder return of...

Palladyne AI (PDYN) is back in focus after reporting Q4 and full year 2025 results, along with a fresh look at its 2026 outlook that combines earnings, guidance and backlog updates in one announcement. See our latest analysis for Palladyne AI. The latest earnings and guidance update landed after a sharp run in the shares, with a 7 day share price return of 21.34% and a 90 day share price return of 55.94% that point to building momentum despite a 14.36% pullback in the last session. The 3 year...

In early March 2026, Renasant reported fourth-quarter 2025 results that beat analyst expectations, approved a US$0.23 per share quarterly dividend for payment on March 31, 2026, and disclosed an insider sale of 1,350 shares by EVP and Chief Accounting Officer Kelly Hutcheson. At the same time, investors grew more cautious about regional banks’ exposure to opaque private credit after a peer’s large loan write-off raised questions about hidden balance sheet risks across the sector. Against...

In February 2026, RLJ Lodging Trust reported fourth quarter 2025 revenue of US$328.59 million and net income of US$0.43 million, alongside full-year 2025 revenue of US$1.35 billion and net income of US$28.51 million, both lower than the prior year. Despite completing a relatively small US$4.3 million share repurchase program covering 586,417 shares, the more striking development was the sharp fall in full-year earnings per share from continuing operations to US$0.01, highlighting pressure on...

WillScot Holdings (WSC) recently made its fencing and perimeter security offering available nationwide, giving the company another way to support construction, event, and high risk sites alongside its modular and storage solutions. See our latest analysis for WillScot Holdings. Despite the fencing rollout, recent trading has been weak, with a 7 day share price return of 10.87% and a 30 day share price return of 13.48%. This has fed into a 1 year total shareholder return decline of 30.54%,...

Napco Security Technologies recently presented at the 47th Annual Raymond James Institutional Investor Conference in Orlando, highlighting its electronic security solutions business and long-term roadmap. The company’s focus on high-margin recurring revenue and ongoing analyst interest in its operating performance has put its evolving business model under a brighter spotlight. Next, we’ll examine how this renewed analyst confidence around recurring revenue growth could influence Napco...

C3.ai (NYSE:AI) is under legal scrutiny after shareholders filed lawsuits alleging securities law violations and breaches of fiduciary duty. The actions follow disappointing financial results, a challenging CEO transition, and claims that material adverse information about sales and growth prospects was not properly disclosed. Regulatory and legal investigations are ongoing, raising questions about the company’s governance and leadership oversight. C3.ai, trading at $9.19, is in the...